# OnCo record nct04422366 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04422366/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04422366", "NCT04422366" ;
  schema:name "Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females"@en ;
  schema:description "A phase 3 trial of HPV quadrivalent vaccine in cervical cancer and vulvar cancer, run by Shanghai Bovax Biotechnology Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04422366/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04422366> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2020-04-28" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/vulvar/>, <https://onco.cc/cancers/vaginal/>, <https://onco.cc/cancers/hpv-associated-vulvar-cancer/>, <https://onco.cc/cancers/vaginal-squamous-cell-carcinoma/> ;
  onco:technologies <https://onco.cc/technologies/hpv-vaccine/>, <https://onco.cc/technologies/interception-vaccination/> ;
  onco:drugs <https://onco.cc/drugs/hpv-quadrivalent-vaccine/> ;
  onco:companies <https://onco.cc/companies/shanghai-bovax-biotechnology/> .